Akıncı Nuran, Bakan Nurten, Karaören Gülşah, Tomruk Senay Göksu, Sökmen Hacı Mehmet, Yanlı Yonca, Akçay Mehmet Erdem
Clinic of Anaesthesiology and Reanimation, İstanbul Ümraniye Training and Research Hospital, İstanbul, Turkey.
Turk J Anaesthesiol Reanim. 2016 Feb;44(1):13-20. doi: 10.5152/TJAR.2016.09483. Epub 2016 Feb 1.
This study aimed to compare 50 mg dexketoprofen vs. 1 g paracetamol that were parenterally administered before endoscopic retrograde cholangiopancreatography (ERCP) under sedoanalgesia with comparable anaesthesia depth regarding haemodynamic, pain, narcotic analgesic requirement, recovery and post-procedural cognitive functions.
Overall, 80 ASA I-III patients aged 18-75 years who were undergoing scheduled ERCP were randomly assigned into three groups. In all patients, the mini-mental test (MMT) was conducted before the procedure. No drug was administered to controls (Group C; n=26); patients were transferred to ERCP unite 30 min after parenteral dexketoprofen (50 mg) in group D (n=27) and paracetamol (1 g) in group P (n=27). The standard monitoring was applied. After intravenously administering loading doses of midazolam (0.02 mgkg) and propofol (1 mg kg(-1)), propofol infusion was administered at a dose of 2-4 mg kg(-1) h(-1) to maintain a bispectral index value of 50-70. Fentanyl (0.05 μg kg(-1)) was intravenously administered when patients experienced pain. Haemodynamic effects, additional analgesic requirement, adverse effects during procedure, time to reach Aldrete score of 9 and satisfaction of an endoscopist and patient were recorded. MMT was repeated 3 h after completing the procedure.
Fentanyl requirement during the procedure was significantly low in group D (p<0.05). Apnoea during the procedure and nausea after the procedure were least common in group D while significantly lower than group C (p<0.05). There was no significant difference with respect to MMT scores and endoscopist's satisfaction, while patient satisfaction was greater in group P.
Parenterally administered dexketoprofen provided better haemodynamic effect and pain control, thereby decreasing incidence of adverse events by reducing the requirement for narcotic analgesics.
本研究旨在比较在镇静镇痛下,麻醉深度相当的情况下,内镜逆行胰胆管造影术(ERCP)前静脉注射50毫克右酮洛芬与1克对乙酰氨基酚对血流动力学、疼痛、麻醉性镇痛药需求、恢复情况及术后认知功能的影响。
总共80例年龄在18至75岁、接受择期ERCP的美国麻醉医师协会(ASA)I-III级患者被随机分为三组。所有患者在手术前均进行简易精神状态检查(MMT)。对照组(C组;n=26)不给予任何药物;D组(n=27)静脉注射右酮洛芬(50毫克)、P组(n=27)静脉注射对乙酰氨基酚(1克)30分钟后将患者转运至ERCP手术室。采用标准监测。静脉注射负荷剂量的咪达唑仑(0.02毫克/千克)和丙泊酚(1毫克/千克)后,以2-4毫克/千克·小时的剂量输注丙泊酚以维持脑电双频指数值在50-70。患者出现疼痛时静脉注射芬太尼(0.05微克/千克)。记录血流动力学效应、额外镇痛需求、手术期间的不良反应、达到Aldrete评分9分的时间以及内镜医师和患者的满意度。手术完成后3小时重复进行MMT。
D组手术期间芬太尼需求量显著较低(p<0.05)。D组手术期间呼吸暂停和术后恶心最不常见,且显著低于C组(p<0.05)。MMT评分和内镜医师满意度方面无显著差异,而P组患者满意度更高。
静脉注射右酮洛芬可提供更好的血流动力学效应和疼痛控制,从而通过减少麻醉性镇痛药的需求降低不良事件的发生率。